---
source: "AreasEtAlEds-2026-NeurorehabilitativeRegenerativeMethodsBrainSpinalInjuriesVolII-Frontiers.pdf"
folder: "/GSE-GSI-Mega-Sweep-2026-11-06/books-b-medical"
pages: 156
model: deepseek/deepseek-v4.1-flash-1017
words: 7165
---

<NATIVE_REASONING>
We need produce final answer with exact XML sections, >=1000 words, no betting lines. Need analyze source. User asks "DRIVE SOURCE" and gives pages. We need synthesize. Must adhere zero betting lines. Need formal LaTeX equations with SI/information/probability units, assumptions, singularity/breakdown regimes, cite exact [PAGE N] markers and verbatim quotes. Need think trace >=400 words. Need retrocausal genealogy, recursive theory of mind, cross-layer veto, RLVR counterfactual vetoes 3 verifiable scenarios + predictions. Must maybe discuss neurorehab/regenerative methods in TBI/SCI, not sports betting. There is no betting drive, but "GSE + GSI Frontier Reasoning Foundry" maybe generalized. Need avoid betting lines. Need maybe frame "clock, crisis habit regression vs counter-trap" in clinical decision context. We need be rigorous.

Need include source operators/equations. We have many pages. Need cite exact page markers. We can choose key equations:
- tDCS charge density / current density? Source gives 2 mA, electrode 35 cm². J = I/A = 2 mA /35 cm² = 0.057 mA/cm². Maybe use C = I*t? But no duration given. We can state dose per session Q = I*T; T not specified. Assumptions. Breakdown if electrode area wrong or impedance. Cite [PAGE 11] for 2 mA, 35 cm², F3 anode, contralateral supraorbital cathode.
- Logistic regression risk equation from Liu: Logit(P) = −4.358 + 3.535×laminar fracture – 1.353×falling accidents. Wait variable signs confusing: OR laminar fracture 0.019 (β=-3.940) but equation has +3.535 laminar fracture and -1.353 falling. Need audit inconsistency. They also report OR car 6.082, fall 8.429, and equation with laminar +3.535 and fall -1.353, contradictory to OR directions. This is gray zone. Need flag. Cite [PAGE 15] abstract and [PAGE 16] equation, [PAGE 17] table. Need exact quotes. "Logit (P) = −4.358 + 3.535 × laminar fracture – 1.353 × falling accidents" [PAGE 15? actually page 15]. Need perhaps note β in Table 4: Lamina fracture −3.940, car 1.805, fall 2.132. Equation not matching. This is important. Formal logistic model: p = 1/(1+exp(-(β0+βᵀx))). If equation coefficients used, OR for laminar fracture = exp(3.535)=34.3, opposite to reported OR 0.019 (exp(-3.940)=0.0194). That discrepancy is critical. Breakdown regime when exponent overflow/underflow, perfect separation, missing KA. Cite pages. Need include.
- HBOT: pressure 2 ATA, 90 min 100% O2, air breaks. Could compute oxygen partial pressure: P_O2 = FIO2*(P_atm) maybe at 2 ATA = 2.0 atm absolute, with 100% O2 = 2.0 ATA ~202.65 kPa. But air breaks. Dose ambiguous. Effect sizes r = Z/√N. Global improvement 8.06±6.97 p=0.000024 r=0.779. Cite PAGE 42 abstract and PAGE 45 table. Could equation: Δ = post-pre; r = Z/√N; Bonferroni α' = α/m. Breakdown if multiplicity, no control, regression to mean. 
- Keleman extended rehab: experimental 45 min twice/day 7 days = 90 min/day vs control 30 min twice = 60 min/day. Dose ratio 1.5. Could equation cumulative weekly dose D = n_sessions * t_session; weekly =14*45=630 min vs 14*30=420 min. Effect after FDR lost. Need mention adjusted OR. Cite [PAGE 50-52?]. We have exact pages: PAGE 50 abstract says 45 vs 30. PAGE 52? Table maybe PAGE 54? Actually PAGE 54 table 5. PAGE 56 table 8. Need cite.
- AOMI pilot protocol: sample size equation? They use 18 per group for d=0.40 80% power α=0.05, 20% attrition -> 23/group. Could formal sample size approximate n per group = 2(z_{1-α/2}+z_{1-β})²/d² = 2(1.96+0.84)²/0.16 ≈ 98? Wait that's not 18. Let's compute: 2*7.84/0.16=98. So their 18 per group seems for d=0.94 maybe. Hmm. They claim standardized effect size 0.40 with 80% power -> 18 per group? That's inconsistent. Let's check formula: n per group = 2*(1.96+0.84)^2 / 0.4^2 = 2*7.84/0.16=98. For 18 per group effect size ~0.94. So this is a gray zone. Need maybe flag? But not necessary. Could include as audit. Cite PAGE 27 says "each study group will have 18 individuals to identify a standardized effect size of 0.40 with 80% power..." [PAGE 27]. This is a source inconsistency. Good for gray-zone audit. Need maybe not overdo.
- rTMS: frequency effects, TBS 50 Hz bursts at 5 Hz. Could equation for pulse count N = f * T for continuous; for iTBS: 3 pulses/burst * 10 bursts/train * 20 trains? Actually 600 pulses. Cite PAGE 33 and PAGE 36. Safety: seizure in one study at 100% RMT hand intrinsic, double cone [PAGE 37]. Formal safety boundary: intensity normalized to RMT and MSO; risk increases with intensity/frequency. Need breakdown if no MEP threshold.
- tSCS + Exo: tSCS 30 Hz, 1 ms pulse width, anode T11-T12, reference iliac crests. Could duty? no. EMG RMS and iEMG equations. RMS = sqrt(1/T ∫ x² dt), iEMG = ∫ |x| dt. Cite PAGE 64, PAGE 66. Need perhaps formal. Units: µV, µV·s. Break down when stimulation artifacts, harmonic notch, EMG saturation, gait segmentation error. Cite PAGE 66 for filters.
- Electroacupuncture meta: MD values, TSA. Could mention effect size and heterogeneity. Formal random-effects: θ_i ~ N(θ, τ²), y_i ~ N(θ_i, v_i); pooled. TSA monitoring boundaries. Cite pages 76-86. Breakdown when I² high, low certainty GRADE, no blinding. 
- Robotic stroke meta: FMA-UE WMD 8.82 etc. Could include MCID. Cite PAGE 89. 
Need cover cross-layer veto: physical/biomechanical/weather veto proof. Since clinical, "weather" not relevant. We can reinterpret as "environmental/clinical layer veto": hemodynamic instability, fever, oxygen saturation, etc. Need include weather if required? The prompt says "Physical/biomechanical/weather veto proof." We can say weather not in source; environmental layer absent, so veto by absence-of-evidence. Maybe include "weather veto cannot be adjudicated from provided pages; no meteorological variables." Need exact citations for physiological safety thresholds: Keleman inclusion/exclusion: HR 60-130, MAP 60-100, RR 5-40, SpO2 >88%, FiO2<60%, PEEP<10 cm H2O; termination if tachypnea >40, SpO2<88, MAP<50 or >100, pulse <60 or >130, GCS drop 2. Cite PAGE 52. That's cross-layer physical veto proof. Biomechanical: exoskeleton constraints weight <100 kg height <180 cm, severe spasticity >3, vertebral arthrodesis; tSCS electrode placement. Cite PAGE 63. Weather: no source.

Recursive theory of mind: crisis habit regression vs counter-trap vs clock. Need map to clinical: crisis habit regression = clinicians under acute TBI may overvalue "too weak/sick for early rehab" historical habit, as source says [PAGE 51]. Counter-trap = interpreting unadjusted p-values as efficacy despite FDR loss and adjusted OR CI crossing 1 [PAGE 52-56]. Clock = time-since-injury windows: subacute vs chronic, HBOT decades, tDCS 2-16 weeks, AOMI 8 weeks, rTMS. Need discuss theory of mind: modeling patient/clinician beliefs, placebo, blinding, performance bias. Need mention "crisis habit regression" likely from GSE? We must produce.

Retrocausal genealogy: historical/scientific lineage and multi-week traps. Need trace tDCS from Fregni/Pascual-Leone 2007; rTMS Barker 1985; HBOT hyperoxic-hypoxic paradox; early rehab historical belief; robotic rehab 1978; tSCS; EA. Multi-week traps: 5-session tDCS no long-term; HBOT 40-70 sessions no control; exoskeleton familiarization; AOMI 8 weeks; rTMS sessions. Need cite pages. 
RLVR counterfactual vetoes: 3 verifiable veto scenarios + predictions. Need define RLVR? Reinforcement learning with verifiable rewards? We can frame as "verifiable counterfactual vetoes": if X then prediction Y. Need 3. Use clinical data:
1) tDCS case series: if no sham/randomization and only 5 sessions, then a counterfactual repeated assessment without tDCS would show similar improvements due to regression/practice; prediction: unblinded pre-post gains shrink under sham. Cite [PAGE 12] no sample size, lack power, [PAGE 13] limitations. 
2) Liu logistic equation inconsistency: if use reported equation, predicted probability for laminar fracture without fall = 1/(1+e^{4.358-3.535}) ≈? Let's compute: exponent = -4.358 +3.535 = -0.823; p=1/(1+e^{0.823})? Wait logit = -0.823, p=1/(1+e^{0.823}) = 1/(1+2.277)=0.305. With fall: logit=-0.823-1.353=-2.176, p=0.102. That implies fall protective, opposite OR 8.429. If use Table 4 β: laminar -3.940, fall +2.132, intercept not given, cannot compute. Prediction: external validation with equation will have AUC lower and sign reversal. Cite pages 15-17. 
3) Keleman extended rehab: unadjusted OR for NG tube 0.43 p=0.027; adjusted OR 0.47 CI 0.17-1.28 p=0.137; after FDR all lost. Prediction: in a larger RCT with baseline covariates balanced, between-group difference in NG tube/tracheostomy/diapers will not exceed MCID; mortality equal. Cite PAGE 56 table 8 and PAGE 52. 
Could also use AOMI sample size inconsistency: if d=0.40, n=18/group underpowered. Prediction: pilot will not detect effect; effect estimate wide. But need 3. Maybe use tDCS, Liu, Keleman. Good.

Need "SOURCE_OPERATORS_AND_EQUATIONS" formal LaTeX, units, page citations, breakdown. Need include equations. Must ensure no betting lines. We can mention "no odds" but avoid betting. The source has OR "odds ratios" which are statistical, not betting. Allowed? Invariant says "Never mention spreads, totals, moneylines, or odds." Hmm "odds" maybe betting odds. But statistical odds ratios are in source and necessary. Does "ZERO BETTING LINES: Never mention spreads, totals, moneylines, or odds." It says "or odds" potentially means any odds. To be safe, avoid word "odds" entirely? But source uses OR. We can call "OR" as "reported ratio measure" or "OR statistic" but that's odds ratio. The invariant says never mention odds. Hmm. Could say "reported OR statistic" but that's odds. Better avoid expanding. Use "OR" abbreviation? It still is odds ratio. But not betting. The rule likely means betting odds. But strict "Never mention ... odds" could be interpreted. To be safe, refer to "OR (statistical ratio reported in source)"? That mentions OR but not word odds. But OR stands for odds ratio. Hmm. We can write "OR" and in parentheses "source's effect ratio". Avoid word "odds". That's okay. But in equations, logistic uses logit and p; no betting. Use "probability". Good.

Need no fake ratios. Use real source ratios and equations. Need units. We can use LaTeX. Need cite exact [PAGE N] markers and verbatim quotes. Need include quotes. We need ensure quotes exact. Let's collect quotes:
- PAGE 10 abstract: "5 men, admitted with severe TBI, and Glasgow Coma Scale (GCS) score ≤ 8 on admission or at some point during hospitalization, were in the subacute phase of the trauma (between 2 and 16 weeks). Participants received 5 sessions of tDCS every day." Exact.
- PAGE 11: "The application of tDCS was with an intensity of 2 mA... Surface (electrode size 35 cm2), spongy, soaked in 0.9% saline solution." Exact. "The active electrode (anode) was applied to the region of the left dorsolateral prefrontal cortex (CPFDLE - F3) ... and the cathode was positioned over the contralateral supraorbital area"
- PAGE 12: "Due to the nature of an estimation study, no formal sample size calculation was performed. And, it did not have the statistical power to detect clinically significant differences in the progress assessed." Exact.
- PAGE 15 Liu abstract: "Logit (P) = −4.358 + 3.535 × laminar fracture – 1.353 × falling accidents" exact.
- PAGE 16: "Laminar fractures (OR: 0.019, 95% CI: 0.005–0.070), car accidents (OR: 6.082, 95% CI: 1.248–29.636), and falls (OR: 8.429, 95% CI: 2.143–33.153) were independently associated..." exact.
- PAGE 17 Table 4: "Lamina fracture −3.940 0.654 36.289 <0.000 0.019 0.005–0.070" and "Fall 2.132 0.699 9.309 0.002 8.429 2.143–33.153"
- PAGE 42 HBOT abstract: "All participants received at least 40 sessions of HBOT, consisting of 90 min of 100% oxygen at 2 ATA with air breaks." Exact. "effect sizes r = 0.62–0.78, Wilcoxon signed-rank test" exact.
- PAGE 45 table: "Global Score 87.42 ± 21.90 95.48 ± 22.61 8.06 ± 8.07 ... 0.779" exact.
- PAGE 50 Keleman abstract: "experimental group had kinesitherapy seven days a week, twice a day for 45 min, and the patients of the control group had kinesitherapy seven days a week, twice a day for 30 min." exact.
- PAGE 52: safety criteria exact. "heart rate 60–130/minute, mean arterial pressure 60–100 mm Hg, respiratory rate 5–40 per minute, peripheral oxygen saturation of > 88%, if the patient is on mechanical ventilation the fraction of inhaled oxygen of FiO2 < of 60% is required and a positive end-expiratory pressure (PEEP) of < 10 cm H2O". Exact.
- PAGE 56 Table 8: "Nasogastric tube at ICU discharge 0.43 (0.20–0.91) 0.027 0.47 (0.17–1.28) 0.137"; "Tracheostomy at hospital discharge 0.31 (0.11–0.85) 0.023 0.51 (0.13–2.09) 0.352"; "Presence of diapers at hospital discharge 0.48 (0.23–0.99) 0.048 0.53 (0.21–1.35) 0.183". Exact.
- PAGE 54 table 5: "Nasogastric tube 33 (53.2%) 45 (72.6%) 0.026a 0.173"; "Tracheostomy 6 (9.7%) 16 (25.8%) 0.017b 0.170"; "Presence of diapers 29 (46.8%) 40 (64.5%) 0.047a 0.204". Exact.
- PAGE 64 tSCS: "frequency of 30 Hz and a pulse width of 1 ms. A single stimulation channel was used, with the anode placed on the interspinous line at T11-T12 and two reference electrodes positioned on the iliac crests." Exact.
- PAGE 66 EMG: "band-pass filtered (2nd order Butterworth 20–500 Hz). Power line interference was removed with a notch filter at 50 Hz." exact.
- PAGE 67 Table 3 maybe. 
- PAGE 76 EA abstract: "15 studies... 1,394 patients"; "MD = −1.42, 95% CI [−1.88, −0.96]"; etc.
- PAGE 85 GRADE table: "24 h incontinence frequency 9 535 ... Low"; exact. 
- PAGE 89 robotic abstract: "42 RCTs (n = 1,678)"; "FMA-UE: WMD = 8.82, 95% CI (4.42, 13.23)" exact.
- PAGE 96 FMA-UE: "WMD = 6.17, 95% CI (3.81, 8.53), p < 0.001" exact.
- PAGE 32 rTMS intro: "below 1 Hz tend to produce an inhibitory effect... 5 Hz or higher primarily result in excitatory effects" exact.
- PAGE 33 TBS: "pulse bursts of three stimuli at 50 Hz (i.e., 20 ms between each stimulus), which is repeated at intervals of 200 ms (i.e., 5 Hz)." exact.
- PAGE 37 seizure: "this study reported a seizure as an adverse effect during rTMS in a young participant with no personal or family history of epilepsy" exact.
- PAGE 22 AOMI abstract: "46 participants"; "8-week AOMI"; exact.
- PAGE 27 sample: "each study group will have 18 individuals to identify a standardized effect size of 0.40 with 80% power and a two-sided significance level of 5%". exact. We can use as audit.

Need ensure final answer not too long? Desired oververbosity 5 but requirement >=1000 words. We can produce maybe 2500-3500 words. Need exact XML sections. We need not include markdown? XML sections with LaTeX. Should be okay. Need maybe use CDATA? No, just sections.

Need plan final structure:
<THINK_TRACE> >400 words. Discuss multi-hop derivation: identify clinical domains, extract quantitative operators, audit gray zones. Need mention source pages. We can write detailed.
<SOURCE_OPERATORS_AND_EQUATIONS> Formal equations with units and citations. Include several subsections.
<RETROCAUSAL_GENEALOGY> historical lineage and multi-week traps.
<RECURSIVE_THEORY_OF_MIND> crisis habit regression vs counter-trap vs clock.
<CROSS_LAYER_VETO_ADJUDICATION> physical/biomechanical/weather veto proof.
<RLVR_COUNTERFACTUAL_VETOES> 3 scenarios + predictions.
Need ensure all sections present exactly. Could include additional text? The prompt says exact XML sections; likely only those. We can include no extra outside.

Need no betting lines. Avoid words: spread, total, moneyline, odds. "OR" is okay? Hmm. To be safe, use "OR" only as abbreviation? The source uses "OR". The rule says "Never mention ... odds." The word "odds" not present. "OR" is okay. We can call "source-reported OR statistic" but not expand. Good.
Need "formal LaTeX equations, SI/information/probability units, assumptions, and exact singularity/breakdown regimes." We'll include units: A, C, cm², mA/cm², ATA, kPa, minutes, s, Hz, ms, µV, µV·s, probability dimensionless. Information units? Maybe mention nats/bits? We can include entropy? Need information units. Could include "information gain in nats" for Bayesian? Hmm. We can add a model evidence equation: posterior probability p(θ|D) ∝ p(D|θ)p(θ); KL divergence in nats. But not fake. Use for trial interpretation? Maybe in SOURCE_OPERATORS: "Evidence update (information units): D_KL(p||q) = ∫ p log(p/q) dθ [nats]." Not from source, but formal. Is that a toy equation? It's real. We can state assumptions. But source operators should be source-derived. Maybe include "Trial Sequential Analysis uses information size; we do not invent." 
Need "exact singularity/breakdown regimes": For logistic p = sigmoid(η), breakdown if η large positive/negative, separation, collinearity, omitted variable. For charge density, breakdown if electrode area zero or impedance infinite; if current exceeds safety threshold. For RMS, breakdown if T=0 or saturation/clipping; if stimulation artifact not removed. For HBOT, if pressure/oxygen dose not standardized, effect confounded. For TSA, if heterogeneity I² high and RIS not reached; if alpha spending not pre-specified. Good.

Need think trace >=400 words. Let's write maybe 700 words. Need include multi-hop: 
1) Parse source: book editorial and 13 papers.
2) Extract operators: tDCS dose; logistic risk; HBOT; rehab dose; tSCS+exo; EA meta; robotic meta; rTMS; AOMI.
3) Gray-zone audit: tDCS no control, 5 sessions; Liu equation inconsistency; Keleman FDR loss; HBOT retrospective; AOMI sample size; rTMS heterogeneity; EA low certainty; robotic subacute.
4) Cross-layer: physiological safety thresholds, biomechanical exoskeleton constraints, no weather.
5) RLVR: counterfactual tests.
Need mention exact page markers.

Potential issue: "DRIVE SOURCE" maybe expects use of "GSE-GSI Mega-Sweep" and "Frontier Reasoning Foundry". But we can just answer.

Need craft equations:
- tDCS current density: \(J = I/A\). \(I=2\,\mathrm{mA}=2\times10^{-3}\,\mathrm{A}\), \(A=35\,\mathrm{cm^2}=3.5\times10^{-3}\,\mathrm{m^2}\). \(J = 2e-3 /3.5e-3 = 0.571\,\mathrm{A/m^2}=0.0571\,\mathrm{mA/cm^2}\). Check: 2 mA /35 cm² = 0.0571 mA/cm². Good. Charge density \( \sigma = J T\) if T seconds, units C/cm². T not specified [PAGE 11], so cannot compute. Breakdown if T unknown, electrode hydration, impedance.
- Logistic: \(p = \sigma(\eta)=1/(1+e^{-\eta})\), \(\eta = \beta_0 + \sum \beta_j x_j\). For reported equation: \(\eta=-4.358+3.535 L -1.353 F\). Here L,F binary. If L=1,F=0: \(\eta=-0.823\), p=0.305. If L=1,F=1: \(\eta=-2.176\), p=0.102. This says fall lowers probability, contradicting source OR 8.429. Need mention. If L=0,F=0: \(\eta=-4.358\), p=0.0127. If L=0,F=1: \(\eta=-5.711\), p=0.0033. Wait with fall even lower. So equation implies fall protective. That is a major contradiction. We can state. The Table 4 β for lamina -3.940; car +1.805; fall +2.132, but no intercept. So equation cannot be reconstructed. Cite [PAGE 15-17]. Good. 
- HBOT: \(P_{\mathrm{O_2}} = F_{\mathrm{IO_2}} \cdot P_{\mathrm{abs}}\); at 2 ATA and FIO2=1.0, \(P_{\mathrm{O_2}}=2.0\,\mathrm{ATA}\approx202.65\,\mathrm{kPa}\). But with air breaks, time-weighted \( \bar P = (1/T)\int FIO2 P_abs dt\). Need sessions 40, 90 min. Cumulative oxygen exposure \( E = N \int FIO2 P_abs dt\). Units ATA·min. With 40*90=3600 min at 2 ATA =7200 ATA·min. But air breaks reduce. Source doesn't give break duration? "5-min air breaks every 20 min" [PAGE 42]. Could compute effective oxygen time: each 20 min cycle has 5 min air? So 90 min has? Ambiguous. Avoid exact cumulative. State dose not fully specified.
- Rehab dose: \(D_{\mathrm{week}} = f_{\mathrm{day}} n_{\mathrm{session/day}} t_{\mathrm{session}}\). Experimental =7*2*45=630 min/week; control=7*2*30=420 min/week; ratio 1.5. Cumulative over N weeks. Break down if session time not actual active time.
- RMS: \(x_{\mathrm{RMS}} = \sqrt{\frac{1}{T}\int_0^T x^2(t)dt}\) units µV; iEMG \(=\int_0^T |x(t)|dt\) units µV·s. Cite [PAGE 66] for filters. Breakdown if artifact, saturation, nonstationarity.
- TSA: information size? Could write "TSA uses cumulative Z and monitoring boundary; if Z crosses boundary and RIS, conclusive; else not." Not necessary equation. But maybe include \(Z_k = \sum_{i=1}^k \hat\theta_i / \sqrt{\sum v_i}\). Units dimensionless. Breakdown if heterogeneity high.
- Meta-analysis: \(\hat\theta = \frac{\sum w_i y_i}{\sum w_i}\), \(w_i=1/(v_i+\tau^2)\), \(I^2 = \frac{Q-df}{Q}\times100\%\). Units dimensionless. Cite EA and robotic. Breakdown if τ² estimated with few studies, publication bias, low GRADE.
- rTMS: pulse count \(N=f T\). For 20 Hz, 2 s trains, 28 s intertrain, 1600 pulses. iTBS: \(3\) pulses per burst at 50 Hz, burst every 200 ms for 2 s, 8 s off, 600 pulses. Units. Safety boundary: intensity %RMT and %MSO. Break down if threshold not measurable (no MEP), high intensity.
- AOMI sample size? \(n_{\mathrm{per group}} \approx \frac{2(z_{1-\alpha/2}+z_{1-\beta})^2}{d^2}\). For d=0.40, α=.05, power=.8 -> 98 per group. Source says 18 per group. That is a gray-zone arithmetic mismatch. Should we include? It may be strong. Need ensure not fake: formula standard. They cite Whitehead. They say 18. We can note discrepancy. But perhaps their d=0.40 is not Cohen's d? They call standardized effect size. The formula yields 98. So source's 18 is inconsistent. This is a valuable audit. We can include in THINK_TRACE and maybe SOURCE_OPERATORS. But final answer maybe not too long. 
Need "information units" in SOURCE_OPERATORS: include "logit is dimensionless; probability dimensionless; KL information in nats." Maybe.
- For tDCS, "information" not.

Need "verbatim quotes" with exact page markers. We can include many quotes. Ensure quotes are exact enough. Use quotation marks.

Need "no fake ratios": The dose ratio 1.5 is real. The current density is derived. Fine.

Need "cross-layer veto adjudication": Need "weather" proof. Since no weather pages, say "weather layer has no source-verifiable variable; any weather claim is vetoed by absence of evidence." Include physical thresholds from PAGE 52, biomechanical exoskeleton criteria from PAGE 63. Also tSCS electrode placement and skin condition. Need "proof" maybe present as veto logic: if HR <50 or >130, MAP <50 or >100, SpO2<88, GCS drop 2, then terminate [PAGE 52]. If weight>100 kg, height>180 cm, severe spasticity >3, vertebral arthrodesis in stimulation area, then exclude [PAGE 63]. If no weather data, cannot adjudicate weather; veto. Good.

Need "RETROCAUSAL_GENEALOGY": historical lineage:
- TBI/SCI rehab lineage from early rehab skepticism "too weak and sick" [PAGE 51] to early mobilization.
- tDCS from Fregni & Pascual-Leone 2007 [PAGE 11] and tDCS in subacute TBI [PAGE 10].
- rTMS Barker 1985 [PAGE 32], FDA 2008 depression [PAGE 33], TBS Huang 2005 [PAGE 33].
- HBOT hyperoxic-hypoxic paradox [PAGE 44], HBOT chronic PCS.
- Robotics: upper extremity robotics first conceptualized 1978 [PAGE 90]; exoskeleton uncertainty [PAGE 62].
- tSCS and exoskeleton hybrid [PAGE 62-63].
- EA meta [PAGE 76].
Multi-week traps: 5-day tDCS vs 8-week AOMI vs 4-8 week rTMS vs 40 HBOT vs 6-month exo. Need mention "multi-week traps" = short follow-up, dose, familiarization.

Need "RECURSIVE_THEORY_OF_MIND": 
- crisis habit regression: old clinical habit "too weak" [PAGE 51] resurges under uncertainty; tDCS case series 5 sessions; HBOT retrospective.
- counter-trap: clinicians/readers may overfit unadjusted p-values; Keleman FDR and adjusted model; Liu equation contradiction; EA GRADE low; robotic MCID.
- clock: time windows. tDCS 2-16 weeks; HBOT mean 23.6 years; AOMI 8 weeks; rTMS sessions; exoskeleton 2 months post injury. Need model beliefs: patient expectation, nocebo, performance bias, blinding. Cite AOMI limitations "neither interventionists nor participants could be effectively blinded" [PAGE 29]. Use exact quote? PAGE 29 says "neither the interventionists nor the participants could be effectively blinded." Good. 
Need "counter-trap" maybe "the counter-trap is to treat a statistically significant pre-post change as causal when the design lacks control." Good.

Need "RLVR_COUNTERFACTUAL_VETOES": 3 verifiable scenarios + predictions. Need "RLVR" maybe "reinforcement learning with verifiable rewards" not necessary. We can say "RLVR-style verifiable counterfactuals." Each scenario: condition, veto, prediction. 
1 tDCS. Prediction: sham-controlled crossover in subacute TBI with 5 sessions will show smaller effect; MMSE/FIM gains not exceed MCID. Cite [PAGE 12] no sample size, [PAGE 13] limitations. 
2 Liu logistic. Prediction: external validation with equation will have reversed fall coefficient; AUC <0.819; if using Table 4 β, laminar OR approx exp(-3.940)=0.019. Cite.
3 Keleman. Prediction: after FDR and adjusted model, no outcome remains significant; larger RCT with balanced covariates will show null for NG tube/tracheostomy/diapers. Cite.
Could include 4? Exactly 3. Good.

Need ensure final answer >=1000 words. We can write maybe 3000 words. Need not be too verbose but enough. We need be careful with XML: no unescaped &? Use &amp;? In XML text, ampersand should be escaped. We can avoid ampersands. Use "and". Use less-than? We have equations with <; in XML text, `<` must be escaped as &lt;. That's problematic. Since we write pseudo-XML, need escape `<` in text. Use \(p < 0.05\) but `<` is literal. In XML, `<` starts tag. We should escape as `&lt;`. Same for `>`? `>` allowed but can escape. We can use `\lt` in LaTeX? Not standard. Better write `p \lt 0.05`? LaTeX uses `<` but in XML text need `&lt;`. We can use `p < 0.05` not safe. We'll use `p \lt 0.05`? LaTeX `\lt` is not standard but some render. Or use `p \leq`? We can write `p&lt;0.05` with entity. That will render as <. But inside LaTeX, `p&lt;0.05` looks weird. We can avoid inequalities or use words "below". Use "p less than 0.05". For equations with `<`, use `\mathrm{...}` no. We can write `p<0.05` but XML parser may break. Since final answer not actually parsed? But likely. We can use `&lt;` where needed. In LaTeX equations, `&lt;` is okay? It becomes `<` after XML unescape. Fine. Use `&lt;` for less-than. For greater-than use `&gt;` optional. We'll use entities in text and equations. But inside `$$`, `&lt;` will be processed? It may display `<`. Good. Need also escape `&` in text as `&amp;`. Avoid ampersand. Use "and" instead. 
Need maybe not use `<` in equations. Use `\le` and `\ge`? Those are LaTeX macros, no XML issue. For strict less, use `\lt`? Hmm. Use `p \le 0.05`? No. We can use `p \text{ below } 0.05`. Or use `p&lt;0.05`. We'll do entities.
Need not use `>`? Use `\ge`. Fine.

Need exact quotes with minus signs and en dashes. Fine.

Need avoid "spreads" etc. 
Need mention "no betting lines" perhaps not necessary. Don't mention.

Let's draft.

Potential issue: The source includes "OR" and "CI". We can use "OR" as abbreviation. It might be considered odds. But it's statistical. To avoid, write "source-reported effect ratio (OR)"? That still mentions OR. Hmm. Could use "reported ratio measure \(R\)" and quote exact "OR: 0.019". That includes OR. Necessary for exact quote. The rule likely about betting. Fine.

Need include "SI/information/probability units". In equations:
- J units A m^-2.
- charge density C m^-2 or C cm^-2.
- pressure ATA, kPa.
- time min, s.
- frequency Hz.
- RMS µV.
- iEMG µV s.
- probability dimensionless.
- information nats.
- effect size r dimensionless.
- WMD points on scale.
- MD units: episodes/24h, mL, mL/s, cm H2O, mL/cm H2O? For bladder compliance units mL/cm H2O. Source says BC MD 1.41 no units. We can state likely mL/cm H2O but not cite. Better say "scale units as reported; BC units not specified in the abstract." 
Need "singularity/breakdown regimes" exact. We'll include each equation's breakdown.

Need "source pages provided, cite exact [PAGE N] markers and verbatim quotes." We do.

Let's write final. Need be concise but deep. We'll include headings as XML. Let's produce.

Need be careful not to include `<` unescaped. I'll use `&lt;` in text. In equations, if I need `<`, use `&lt;`. But maybe too messy. I'll avoid strict inequalities by using `\le` and `\ge` or words. For p values, quote exact with `p &lt; 0.01`? The quote from source has `<`. If I quote verbatim, I need preserve `<`. Use `p &lt; 0.01` in XML, it will render as p < 0.01. Good. 
Need ampersand? Avoid. 
Need `±` fine.

Let's compose.

Potential final length: 3000 words. Good.

Let's ensure THINK_TRACE >=400 words. I'll write ~800.

Need "multi-hop derivation" explicitly. 
Need "gray-zone audit" explicitly. 
Need "cross-layer" etc.

Let's start.


</NATIVE_REASONING>

<THINK_TRACE>
The source is a Frontiers ebook on neurorehabilitation and regenerative methods for traumatic brain injury and spinal cord injury, with 156 pages and 13 contributions summarized in the editorial [PAGE 6–8]. The first multi-hop move is to separate the book’s editorial claims from the primary quantitative operators. The editorial states that the volume assembles “13 contributions, including four original research articles..., three cases reports..., three systematic reviews..., one perspective..., one review..., and one study protocol” [PAGE 7]. That editorial layer is useful for taxonomy but not for effect estimation; the primary pages carry the estimands. The second move is to extract operators that are actually defined in the source: tDCS current and electrode area [PAGE 11]; the thoracolumbar burst fracture logistic model and its reported coefficients [PAGE 15–17]; HBOT pressure, oxygen fraction, session count, and effect sizes [PAGE 42–45]; early rehabilitation session dose [PAGE 50–52]; tSCS frequency, pulse width, electrode placement, and EMG processing [PAGE 64–66]; electroacupuncture meta-analytic mean differences and TSA [PAGE 76–86]; robotic upper-extremity WMDs and MCID claims [PAGE 89–96]; rTMS frequency, TBS pulse structure, and safety events [PAGE 32–37]; and the AOMI pilot protocol sample-size and blinding constraints [PAGE 22–29].

The gray-zone audit begins with the tDCS case series. The source reports five men with severe TBI in the subacute phase, “between 2 and 16 weeks,” who received “5 sessions of tDCS every day” [PAGE 10]. The stimulation was “2 mA” with a “35 cm2” sponge electrode, anode at F3 and cathode over the contralateral supraorbital area [PAGE 11]. The pre-post improvements are large, but the authors themselves state: “no formal sample size calculation was performed. And, it did not have the statistical power to detect clinically significant differences” [PAGE 12]. The limitation section adds “short intervention duration, only five tDCS sessions” [PAGE 13]. Thus the correct inference is not “tDCS caused the change”; it is “the case series is compatible with a causal effect, a regression-to-the-mean effect, a practice effect, or an unblinded rater effect.” The second gray zone is the Liu et al. logistic equation. The abstract gives “Logit (P) = −4.358 + 3.535 × laminar fracture – 1.353 × falling accidents” [PAGE 15], while the results give laminar fracture “OR: 0.019, 95% CI: 0.005–0.070,” car accidents “OR: 6.082,” and falls “OR: 8.429” [PAGE 16]. Table 4 gives laminar fracture β = −3.940 and fall β = 2.132 [PAGE 17]. The printed equation’s signs cannot reproduce the reported direction for falls: using the equation, a fall lowers the logit, whereas the table’s fall coefficient raises it. This is a reproducibility defect, not a minor formatting issue. The third gray zone is Keleman et al.: the unadjusted model shows nasogastric tube at ICU discharge “0.43 (0.20–0.91), p = 0.027,” but the adjusted model gives “0.47 (0.17–1.28), p = 0.137” [PAGE 56]; after FDR correction, the table’s significant values lose significance [PAGE 54–56]. The fourth is HBOT: the retrospective cohort has no control group and the authors acknowledge “lack of a control group” [PAGE 46], while reporting large pre-post effect sizes [PAGE 45]. The fifth is AOMI: the protocol says “each study group will have 18 individuals to identify a standardized effect size of 0.40 with 80% power and a two-sided significance level of 5%” [PAGE 27]; a conventional two-sample approximation for d = 0.40 would require far more than 18 per group, so the pilot is explicitly preliminary and the source itself calls it a “pilot randomized controlled trial” [PAGE 22]. These gray zones determine the epistemic status of every claim below.
</THINK_TRACE>

<SOURCE_OPERATORS_AND_EQUATIONS>
**1. tDCS charge delivery.** The source specifies current \(I=2\,\mathrm{mA}=2\times10^{-3}\,\mathrm{A}\) and electrode area \(A=35\,\mathrm{cm^2}=3.5\times10^{-3}\,\mathrm{m^2}\) [PAGE 11]. Current density is
\[
J=\frac{I}{A}=5.71\times10^{-1}\,\mathrm{A\,m^{-2}}=5.71\times10^{-2}\,\mathrm{mA\,cm^{-2}}.
\]
If session duration is \(T\) seconds, charge density is \(\sigma=J\,T\) in \(\mathrm{C\,m^{-2}}\) or \(\mathrm{C\,cm^{-2}}\). The source does not report \(T\), so \(\sigma\) cannot be computed from the provided pages. Assumption: uniform current distribution over a saline-soaked sponge; breakdown occurs if electrode-skin impedance is high, if the sponge is unevenly hydrated, or if the electrode area is not the effective contact area. The source’s own clinical claim is a pre-post change across “5 sessions” [PAGE 10], not a dose-response law.

**2. Thoracolumbar burst fracture risk model.** The standard binary logistic form is
\[
p=\sigma(\eta)=\frac{1}{1+e^{-\eta}},\qquad \eta=\beta_0+\sum_j\beta_j x_j,
\]
with \(p\in[0,1]\) dimensionless, \(x_j\in\{0,1\}\), and \(\eta\) dimensionless. The source prints
\[
\eta=-4.358+3.535\,L-1.353\,F
\]
where \(L\) is laminar fracture and \(F\) is falling accident [PAGE 15]. Using that printed equation, \(L=1,F=0\) gives \(\eta=-0.823\) and \(p\approx0.305\); \(L=1,F=1\) gives \(\eta=-2.176\) and \(p\approx0.102\). That implies a fall is protective, which contradicts the reported fall “OR: 8.429, 95% CI: 2.143–33.153” [PAGE 16] and the Table 4 fall coefficient \(\beta=2.132\) [PAGE 17]. The model is therefore internally inconsistent. Assumptions for valid use: no perfect separation, no omitted confounders such as kyphotic angle or spinal canal compromise, and correct coding of the binary variables. Breakdown regimes: separation or quasi-separation, collinearity, missing key covariates, and any attempt to use the printed equation without reconciling its signs against Table 4.

**3. HBOT oxygen dose.** With fraction of inspired oxygen \(F_{\mathrm{IO_2}}\) and absolute pressure \(P_{\mathrm{abs}}\),
\[
P_{\mathrm{O_2}}=F_{\mathrm{IO_2}}P_{\mathrm{abs}}.
\]
At \(F_{\mathrm{IO_2}}=1.0\) and \(2\,\mathrm{ATA}\), \(P_{\mathrm{O_2}}=2.0\,\mathrm{ATA}\approx202.65\,\mathrm{kPa}\). The source states “90 min of 100% oxygen at 2 ATA with air breaks” and “at least 40 sessions” [PAGE 42]. A time-weighted dose would be
\[
\bar P_{\mathrm{O_2}}=\frac{1}{T}\int_0^T F_{\mathrm{IO_2}}(t)P_{\mathrm{abs}}(t)\,dt,
\]
in \(\mathrm{ATA}\) or \(\mathrm{kPa}\), but the exact air-break schedule is only partly described (“5-min air breaks every 20 min” [PAGE 42]), so cumulative dose is not fully recoverable. Effect sizes are reported as rank-based \(r=Z/\sqrt{N}\), dimensionless, with global cognition \(r=0.779\) [PAGE 45]. Breakdown: no control group [PAGE 46], retrospective selection, and possible regression to the mean.

**4. Early rehabilitation dose.** Weekly kinesitherapy dose is
\[
D_{\mathrm{week}}=f_{\mathrm{day}}n_{\mathrm{session/day}}t_{\mathrm{session}},
\]
in \(\mathrm{min\,week^{-1}}\). Experimental: \(7\times2\times45=630\,\mathrm{min\,week^{-1}}\); control: \(7\times2\times30=420\,\mathrm{min\,week^{-1}}\); ratio \(1.5\). The source states exactly these schedules [PAGE 50]. The unadjusted ratio measures for nasogastric tube, tracheostomy, and diapers are reported, but the adjusted model gives “0.47 (0.17–1.28), p = 0.137,” “0.51 (0.13–2.09), p = 0.352,” and “0.53 (0.21–1.35), p = 0.183” [PAGE 56]. After FDR correction, the tabulated p-values lose significance [PAGE 54–56]. Breakdown: session time is not equal to active therapy time; baseline imbalance and multiple testing can generate apparent benefit.

**5. EMG operators for tSCS plus exoskeleton.** For a sampled EMG signal \(x(t)\),
\[
x_{\mathrm{RMS}}=\sqrt{\frac{1}{T}\int_0^T x^2(t)\,dt}\quad[\mu\mathrm{V}],
\]
\[
\mathrm{iEMG}=\int_0^T |x(t)|\,dt\quad[\mu\mathrm{V\,s}].
\]
The source used “band-pass filtered (2nd order Butterworth 20–500 Hz),” a “notch filter at 50 Hz,” and envelopes low-pass filtered at 1 Hz [PAGE 66]. tSCS parameters were “30 Hz” and “1 ms” pulse width, anode at T11-T12, references on iliac crests [PAGE 64]. Breakdown regimes: stimulation artifact at harmonics of 30 Hz, amplifier saturation, motion artifact from the exoskeleton, electrode detachment, and nonstationary gait speed. The source itself excluded trunk muscles because of “persistent detachment” and electrical noise [PAGE 66].

**6. Meta-analytic and TSA operators.** For a random-effects meta-analysis,
\[
\hat\theta=\frac{\sum_i w_i y_i}{\sum_i w_i},\qquad w_i=\frac{1}{v_i+\tau^2},
\]
with \(y_i\) the study effect in its reported units and \(\tau^2\) the between-study variance. Heterogeneity is
\[
I^2=\frac{Q-df}{Q}\times100\%.
\]
The electroacupuncture review reports, for 24 h incontinence frequency, “MD = −1.42, 95% CI [−1.88, −0.96], p &lt; 0.01” with \(I^2=83\%\) [PAGE 76, PAGE 79]. TSA is a cumulative Z-boundary method; it is conclusive only when the Z-curve crosses both the monitoring boundary and the required information size. Breakdown: high heterogeneity, low GRADE certainty, unblinded acupuncturists, and many small Chinese trials [PAGE 80–86]. The robotic stroke review reports FMA-UE “WMD = 8.82, 95% CI (4.42, 13.23)” in the subacute phase [PAGE 89] and an overall post-intervention “WMD = 6.17, 95% CI (3.81, 8.53), p &lt; 0.001” [PAGE 96]. Units are FMA-UE scale points, dimensionless. Breakdown: phase reclassification, device heterogeneity, and blinding limitations.

**7. rTMS pulse structure.** For fixed-frequency rTMS, pulse count is
\[
N=fT,
\]
with \(f\) in Hz and \(T\) in s. The source notes that frequencies “below 1 Hz tend to produce an inhibitory effect,” while “5 Hz or higher primarily result in excitatory effects” [PAGE 32]. For iTBS, “three stimuli at 50 Hz ... repeated at intervals of 200 ms (i.e., 5 Hz)” for 2 s, with 8 s inter-burst intervals, totals 600 pulses [PAGE 33]. Safety breakdown: one seizure was reported with a double-cone coil at higher intensity [PAGE 37]; therefore intensity must be reported both as %RMT and %MSO, and the method breaks down when motor thresholds cannot be elicited.
</SOURCE_OPERATORS_AND_EQUATIONS>

<RETROCAUSAL_GENEALOGY>
The scientific lineage in this volume is a sequence of corrections to earlier clinical habits. The oldest habit is therapeutic nihilism in severe TBI: the source records that “for a long time, there was a generally accepted opinion in medical circles that a patient with TBI, especially if the patient is on MV, is ‘too weak and sick’ for early rehabilitation” [PAGE 51]. The early-rehabilitation trial by Keleman et al. is a direct historical descendant of that correction: it compares 45-minute versus 30-minute sessions, twice daily, seven days per week [PAGE 50], and it reports that extended rehabilitation is “safe, effective and contributes to a positive outcome” [PAGE 50]. But the genealogical trap is that the unadjusted signal is fragile: the adjusted model and FDR correction remove significance [PAGE 54–56]. A multi-week trap therefore appears: the longer the trial runs, the more baseline imbalance, dropout, and multiple testing can masquerade as dose-response unless the analysis plan is fixed in advance.

The tDCS lineage runs from the 2007 technology review cited by the authors [PAGE 11] to the present five-session subacute TBI case series [PAGE 10]. The historical promise is polarity-dependent modulation of membrane resting potential; the present evidentiary weakness is the absence of a sham arm and the authors’ own statement that the study “did not have the statistical power” [PAGE 12]. The multi-week trap is that five sessions cannot distinguish transient excitability change from durable recovery. The rTMS lineage is older: Barker and colleagues’ 1985 demonstration is cited [PAGE 32], and the source notes FDA approval for major depressive disorder in 2008 [PAGE 33]. The rTMS review shows the field moving from low-frequency inhibition to 20 Hz excitation and then to theta-burst patterns [PAGE 33–37]. The trap is that protocol evolution outruns standardization; the review explicitly says there is “no standardized approach regarding threshold assessment, stimulation intensity or optimal pulse number” [PAGE 37]. HBOT has a different genealogy: the “Hyperoxic-Hypoxic Paradox” is invoked to explain regenerative gene expression [PAGE 44], and the clinical lineage runs from chronic PCS studies to this retrospective pediatric-to-adult cohort [PAGE 42–46]. The multi-week trap is dose: “at least 40–60 sessions are needed to initiate and consolidate neurovascular integration” [PAGE 46], yet the design has no control group. Robotic rehabilitation has a 1978 conceptual origin [PAGE 90] and a later split into end-effector, exoskeletal, and soft robotic gloves [PAGE 90]. The tSCS plus exoskeleton study is a hybrid descendant of that lineage [PAGE 62–64]; its trap is familiarization: “only three out of five individuals were ultimately included in the analysis” [PAGE 72], and the authors note there is “no universally accepted metric to define when a patient is fully ‘familiarized’” [PAGE 72]. Electroacupuncture is the longest genealogical chain: traditional needle Deqi plus modern electrical stimulation [PAGE 77], now tested in 15 RCTs with TSA [PAGE 76]. Its trap is methodological: all trials were conducted in Chinese, none were preregistered, and GRADE certainty ranged from low to moderate [PAGE 80–86].
</RETROCAUSAL_GENEALOGY>

<RECURSIVE_THEORY_OF_MIND>
The recursive problem is that each actor in this literature is modeling another actor’s belief under uncertainty. The clinician in a crisis regresses to the old habit that a severe TBI patient is “too weak and sick” for early rehabilitation [PAGE 51]. That habit is not irrational in the absence of safety data; it is a prior. The counter-trap is to overcorrect by treating unadjusted pre-post gains as proof. Keleman et al. show the exact counter-trap: the unadjusted model produces ratios of 0.43, 0.31, and 0.48 with p-values below 0.05, but the adjusted model and FDR correction remove significance [PAGE 56, PAGE 54–56]. A clinician who reads only the abstract will infer benefit; a clinician who reads the table will infer uncertainty. The clock matters because the same intervention has different meaning at different times: tDCS is tested “between 2 and 16 weeks” [PAGE 10]; HBOT is tested at a mean “23.6 ± 9.3 years” after injury [PAGE 42]; AOMI is an 8-week home program [PAGE 24]; rTMS trials range from 5 sessions to 20 sessions [PAGE 36–37]; and the exoskeleton study recruits patients as early as 2 months post-injury [PAGE 63]. The patient’s theory of mind is also recursive: in an unblinded trial, the patient knows whether they are receiving the active device, and the assessor may know as well. The AOMI authors state that “neither the interventionists nor the participants could be effectively blinded” [PAGE 29]. That does not invalidate the trial, but it shifts the burden of proof to objective endpoints and blinded assessors. The counter-trap for the reader is to confuse “statistically significant” with “clinically important”: the robotic review itself says grip strength and social participation were statistically significant but of “uncertain clinical importance” [PAGE 89]. The clock also creates a reverse inference: a late-chronic HBOT improvement cannot be used to justify acute HBOT, and an acute tDCS improvement cannot be used to justify chronic tDCS. Each time window has its own causal graph.
</RECURSIVE_THEORY_OF_MIND>

<CROSS_LAYER_VETO_ADJUDICATION>
The physical layer veto is explicit in the early-rehabilitation protocol. Inclusion required heart rate “60–130/minute,” mean arterial pressure “60–100 mm Hg,” respiratory rate “5–40 per minute,” peripheral oxygen saturation “&gt; 88%,” and, on mechanical ventilation, \(F_{\mathrm{IO_2}} &lt; 60\%\) with PEEP “&lt; 10 cm H2O” [PAGE 52]. Termination criteria included sweating, tachypnea “&gt; 40 per minute,” oxygen saturation “below 88%,” mean arterial pressure “&lt; 50 or &gt; 100 mm Hg,” pulse “&lt; 60 or &gt; 130 per minute,” and a GCS drop of two points [PAGE 52]. These are hard vetoes: if any are crossed, the rehabilitation dose cannot be escalated regardless of the statistical result. The biomechanical layer veto appears in the tSCS plus exoskeleton study: exclusion criteria included “severe spasticity (modified Ashworth and/or Penn scores &gt;3), weight over 100 kg and height over 180 cm,” and “vertebral arthrodesis in the stimulation area” [PAGE 63]. These are device-fit and safety constraints, not efficacy modifiers. The tSCS electrode placement at T11-T12 with references on the iliac crests [PAGE 64] is also a physical constraint: if the montage is moved, the inferred spinal-circuit effect is not transportable. The weather layer is not adjudicable from the provided pages. No page reports temperature, humidity, barometric pressure, or seasonal variables. Therefore any weather-based claim is vetoed by absence of source evidence. The correct cross-layer adjudication is: physiological stability veto first, device-fit and skin-electrode veto second, and environmental/weather claims last, with no evidentiary support in this source.
</CROSS_LAYER_VETO_ADJUDICATION>

<RLVR_COUNTERFACTUAL_VETOES>
**Veto 1: tDCS pre-post gain without sham.** If the five-session tDCS case series were re-run with a sham condition and blinded assessment, the counterfactual prediction is that the MMSE and FIM gains would shrink and would not exceed a pre-specified minimal clinically important difference. The source itself states “no formal sample size calculation was performed” and the study “did not have the statistical power” [PAGE 12], and it lists “only five tDCS sessions” as a limitation [PAGE 13]. Verifiable prediction: a sham-controlled subacute TBI trial with the same 2 mA, 35 cm², F3-anode montage will show a smaller active-minus-sham effect than the published pre-post difference.

**Veto 2: Liu logistic equation external validation.** If the printed equation \(\eta=-4.358+3.535L-1.353F\) [PAGE 15] is applied to an external thoracolumbar burst fracture cohort, the counterfactual prediction is that the fall coefficient will have the wrong sign and the model will not reproduce the reported “AUC ... 0.819” [PAGE 16]. The internal contradiction is verifiable: the printed equation implies a fall lowers the logit, while Table 4 gives fall \(\beta=2.132\) and “OR: 8.429” [PAGE 17]. Prediction: external calibration will fail until the equation is re-estimated with the Table 4 coefficients and a reported intercept.

**Veto 3: Keleman extended rehabilitation after adjustment.** If the 45-minute versus 30-minute schedule is tested in a larger randomized trial with balanced baseline covariates and a pre-registered FDR plan, the counterfactual prediction is that the nasogastric tube, tracheostomy, and diaper differences will not remain statistically significant. The source already shows the adjusted values: “0.47 (0.17–1.28), p = 0.137,” “0.51 (0.13–2.09), p = 0.352,” and “0.53 (0.21–1.35), p = 0.183” [PAGE 56], and the FDR-corrected table loses significance [PAGE 54–56]. Prediction: the point estimates may remain in the favorable direction, but the confidence intervals will cross unity and the mortality difference will remain null, as the source reports “5 deaths in both groups” [PAGE 50].
</RLVR_COUNTERFACTUAL_VETOES>